- Joined
- Sep 7, 2014
- Messages
- 3,613
- Reaction score
- 6,632
- Points
- 6,961
This patient
View attachment 395829View attachment 395830
presented with a 4.5 cm right level 2 node, p16+. On resection and search for primary all that was found was a single 4.5 cm node with ENE. Wondering who would do unilateral RT.
I treat per asco guidelines in this situation, which by and large allows for unilateral treatment in this situation.
Sorry, would include unilateral oropharynx in elective volume. Though would consider entire BOT. Regarding post concerning ENE, I kind of agree. Except, firstly, there was no clinical or radiological ENE. Secondly, ENE is not mentioned in the p staging of p16+. Certainly, the trials incorporated the old staging, but it appears ENE isn't much of a prognostic indicator in p16+, which might suggest, contra neck is as low of a risk with or without. Ultimately was originally a cT0N2a oropharynx cancer. I'd probably have treated unilaterally sans surgery if T1N2a tonsil.I would. To me its more of a discussion of involved field versus comprehensive RT. If you've done a really good search including with surgery, you could assume its a T0 and unilateral is reasonable. Contralateral neck is also very salvageable.
Im not sure it makes a lot of sense to treat bilateral necks but nothing in the oropharynx.
I treat per asco guidelines in this situation, which by and large allows for unilateral treatment in this situation.
Sorry, would include unilateral oropharynx in elective volume. Though would consider entire BOT. Regarding post concerning ENE, I kind of agree. Except, firstly, there was no clinical or radiological ENE. Secondly, ENE is not mentioned in the p staging of p16+. Certainly, the trials incorporated the old staging, but it appears ENE isn't much of a prognostic indicator in p16+, which might suggest, contra neck is as low of a risk with or without. Ultimately was originally a cT0N2a oropharynx cancer. I'd probably have treated unilaterally sans surgery if T1N2a tonsil.
Edit: Also, ASCO's recs include considering unilateral RT if N2, but nothing about T0. My question is maybe asking 2 questions: Unilateral in any CUP? And, unilateral if clinically and radiographically negative ENE but pathological ENE?
Thanks. Didn't know this existedThe ASCO guidelines are specific for cancer of unknown primary: https://ascopubs.org/doi/pdfdirect/10.1200/JCO.20.00275
edit: if it's only pathologic ENE without clinical/radiological ENE, I'd agree unilateral RT would be reasonable
Perfick. EOT...The ASCO guidelines are specific for cancer of unknown primary: https://ascopubs.org/doi/pdfdirect/10.1200/JCO.20.00275
edit: if it's only pathologic ENE without clinical/radiological ENE, I'd agree unilateral RT would be reasonable
Yes, just short handing with "p16+"Is it HPV dna positive? 40% of skin cancers are p16+
I would add Cis given our knowledge of ENE.I individually discuss these approaches with each patient. There is no clear evidence on superiority/inferiority of each approach. The more comprehensively one treats, the more toxicity one produces. I tend to treat more limited in patients who are not super fit, elderly.
Another question: Concurrent Cisplatin because of the ENE? No patients with CUP were included in the landmark trials, but one could make the argument that there may be some benefit by adding it?
With ENE would treat CL neck. Could just do level 2 +/- 3.This patient
View attachment 395829View attachment 395830
presented with a 4.5 cm right level 2 node, p16+. On resection and search for primary all that was found was a single 4.5 cm node with ENE. Wondering who would do unilateral RT.
4.5cm node is big. Search should include tors mucosectomy and bilat tonsil. If they didnt do that then its not enough of search ot be omitting bilat neck. Most primaries i believe are found now compared to the historical data